Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 2/20 | 0.65 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.63 |
| ▸ | F2 | P00734 | 4/20 | 0.60 |
| ▸ | MC4R | P32245 | 1/20 | 0.57 |
| ▸ | TFPI | P10646 | 1/20 | 0.56 |
| ▸ | RAMP3 | O60896 | 3/20 | 0.56 |
| ▸ | CALCR | P30988 | 3/20 | 0.56 |
| ▸ | GLP1R | P43220 | 4/20 | 0.55 |
| ▸ | GCGR | P47871 | 3/20 | 0.55 |
| ▸ | SCTR | P47872 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31182616 | 0.90 | RAMP3 (0.63) | F2RAMP3CALCRGLP1RGCGR | |
| SCHEMBL29801157 | 0.89 | APLNR (0.60) | APLNRC5AR1F2RAMP3CALCR | |
| SCHEMBL30524357 | 0.89 | APLNR (0.67) | APLNRC5AR1CALCRGLP1RGCGR | |
| SCHEMBL30437391 | 0.89 | APLNR (0.67) | APLNRC5AR1MC4RTFPICALCR | |
| SCHEMBL30930534 | 0.89 | F2 (0.60) | APLNRC5AR1F2CALCRGLP1R | |
| SCHEMBL31688331 | 0.89 | APLNR (0.58) | APLNRC5AR1F2MC4R | |
| SCHEMBL30495678 | 0.89 | C5AR1 (0.66) | APLNRC5AR1MC4RTFPI | |
| SCHEMBL29798261 | 0.88 | C5AR1 (0.60) | APLNRC5AR1MC4RTFPICALCR | |
| SCHEMBL30262218 | 0.88 | C5AR1 (0.59) | C5AR1RAMP3CALCRGLP1RGCGR | |
| SCHEMBL31182477 | 0.88 | APLNR (0.64) | APLNRC5AR1F2TFPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250297282-A1 | VIRAL-BINDING PROTEIN AND RELATED REAGENTS, ARTICLES, AND METHODS OF USE | JUNO THERAPEUTICS GMBH (DE) | 2025-09-25 | — | — | US | disclosed |